What Artiva Biotherapeutics Inc's executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 2 | 22 |
| Sells | 12 | 19 |
| Total trades | 22 | 69 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 366,503 | 12,570,941 |
| Disposed | 218,793 | 319,384 |
| Net activity | +147,710 | +12,251,557 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Aslan Fred | Chief Executive Officer | Oct 06 | Open-market sale · S | −23,463 | $7.20 | −$169K | 1,519,606 |
| Aslan Fred | Chief Executive Officer | Oct 05 | Sale for tax withholding · S | −61,696 | $6.84 | −$422K | 1,543,069 |
| Horan Christopher | Chief Tech Operations Officer | Oct 05 | Sale for tax withholding · S | −10,340 | $6.84 | −$70.7K | 312,744 |
| Banerjee Subhashis | Chief Medical Officer | Oct 05 | Sale for tax withholding · S | −1,099 | $6.84 | −$7.51K | 169,848 |
| Bush Jennifer | COO, CLO, Compliance Officer | Oct 05 | Sale for tax withholding · S | −8,370 | $6.84 | −$57.2K | 366,159 |
| Aslan Fred | Chief Executive Officer | Sep 15 | Grant / award · A | +110,000 | — | — | 1,604,765 |
| Aslan Fred | Chief Executive Officer | Sep 10 | Grant / award · A | +45,000 | — | — | 1,494,765 |
| Banerjee Subhashis | Chief Medical Officer | Sep 09 | Grant / award · A | +30,000 | — | — | 170,947 |
| Bush Jennifer | COO, CLO, Compliance Officer | Sep 09 | Grant / award · A | +45,000 | — | — | 374,529 |
| Horan Christopher | Chief Tech Operations Officer | Sep 09 | Grant / award · A | +40,000 | — | — | 323,084 |
| Miralles Gines Diego | President & Head of R&D | Sep 09 | Grant / award · A | +45,000 | — | — | 122,500 |
| Aslan Fred | Chief Executive Officer | Sep 08 | Open-market sale · S | −23,429 | $10.92 | −$256K | 1,449,765 |
| Aslan Fred | Chief Executive Officer | Sep 03 | Sale for tax withholding · S | −61,888 | $11.16 | −$690K | 1,473,194 |
| Bush Jennifer | COO, CLO, Compliance Officer | Sep 03 | Sale for tax withholding · S | −8,391 | $11.16 | −$93.6K | 329,529 |
| Horan Christopher | Chief Tech Operations Officer | Sep 03 | Sale for tax withholding · S | −10,366 | $11.16 | −$116K | 283,084 |
| Banerjee Subhashis | Chief Medical Officer | Sep 03 | Sale for tax withholding · S | −1,100 | $11.16 | −$12.3K | 140,947 |
| Banerjee Subhashis | Chief Medical Officer | Aug 27 | Open-market sale · S | −8,222 | $12.01 | −$98.7K | 142,047 |
| Banerjee Subhashis | Chief Medical Officer | Aug 27 | Exercise / conversion · M | +5,306 | $1.92 | +$10.2K | 150,269 |
| Banerjee Subhashis | Chief Medical Officer | Aug 18 | Open-market sale · S | −429 | $12.00 | −$5.15K | 144,963 |
| Banerjee Subhashis | Chief Medical Officer | Aug 18 | Exercise / conversion · M | +429 | $1.92 | +$824 | 145,392 |
Loading...
